Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in the Central Nervous System (CNS) disorders and other rare disorders. Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in the Central Nervous System (CNS) disorders and other rare disorders.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.28 | 1.28 | 1.28 | 0 | 0 | CS |
4 | 0 | 0 | 1.28 | 1.28 | 1.28 | 0 | 0 | CS |
12 | -2.52 | -66.3157894737 | 3.8 | 5 | 1.15 | 99452 | 2.79783961 | CS |
26 | -12.4208 | -90.6574798552 | 13.7008 | 16.1584 | 1.15 | 3931416 | 5.36717 | CS |
52 | -203.52 | -99.375 | 204.8 | 247.04 | 1.15 | 2187197 | 13.42509681 | CS |
156 | -6257.92 | -99.9795501022 | 6259.2 | 6950.4 | 1.15 | 1859181 | 1468.10584859 | CS |
260 | -5374.72 | -99.9761904762 | 5376 | 25344 | 1.15 | 2643341 | 8002.16112541 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales